Gerard Van Spall Appointed as Founding Committee Member of IBSA’s Cyprus Chapter of its European Branch

24 January 2017
spotlight_insights_25.jpg
ibsa

It is a privilege to announce that Vistra is and has been extensively involved in The International Business Structuring Association (‘IBSA’). We have been supporting IBSA worldwide inter alia Dubai, Luxembourg, London and now have members in all of the jurisdictions that Vistra and IBSA jointly operate in. 

IBSA is the worldwide community for practitioners dealing with international business structuring and regulatory compliance. The Association enables international business advisors to access and exchange knowledge, develop professional relationships and discover new business opportunities.

IBSA is introducing and welcoming Gerard Jan Van Spall, Managing Director at Vistra Cyprus, as founding committee member to strengthen the Cyprus team and further assist in the growth of IBSA in Cyprus. Gerard will be present during the upcoming Cyprus Branch meeting to be held on the evening of Thursday 26 January. This event will take place at the Centre of Visual Arts & Research, Nicosia, and will run from 17:30 until 20:30.  This meeting will specifically discuss the implementation of the OECD’s BEPS initiatives in Cyprus, Luxembourg, Netherlands and Malta, amongst other countries, with reference to the implementation of so-called patent box regimes in these countries. Treaty access limitations in respect of the double tax treaties entered into by these countries, as well as the effect of the Common Reporting Standard on entrepreneurial clients and their requirement to disclose beneficial ownership of their holding companies will be discussed too. 

Gerard will also be present during the IBSA workshop on 27 January examining the international tax issues relevant to the expansion of the fictitious Polycon Lens company, as it morphs into the multinational Eyemax corporation throughout its generational journey. The workshop will start with an explanation of an entrepreneur’s invention developed by the manufacturing entity, the company's overseas expansion with warehousing facilities, representative offices and then sales subsidiaries, corporate acquisitions made to expand the global reach of the company followed by an IPO as the company’s financial requirements dictate for its future growth.  The appropriate holding company regimes, along with financing and licensing techniques will be examined, together with investment vehicles for real estate and other fringe activities, with the final stage being the creation of a private equity fund under the newly branded Eyemax umbrella.